Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
  1. 2022
  2. Udgivet
  3. Udgivet

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 flere, Rosano, G. M. C., Rossing, P., Rydén, L., Santilli, F., Schumm-Draeger, P. M., Vandvik, P. O., Vilsbøll, T., Wanner, C., Wysham, C. & Standl, E., dec. 2022, I: Cardiovascular Diabetology. 21, 1, 50.

    Publikation: Bidrag til tidsskriftKommentar/debatpeer review

  4. Udgivet
  5. E-pub ahead of print

    Organic anion transporter gene variants associated with plasma exposure and long-term response to atrasentan in patients with diabetic kidney disease

    Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J. V., Bakris, G. L., Correa-Rotter, R., Hou, F-F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, P., Tobe, S., Parving, H-H., de Zeeuw, D. & Heerspink, H. J. L., 27 jul. 2022, (E-pub ahead of print) I: Clinical Pharmacology and Therapeutics.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  6. Udgivet
  7. E-pub ahead of print
  8. Udgivet
  9. Udgivet
  10. Udgivet
  11. Udgivet

    406-P: Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Trial

    Frimodt-Møller, M., Salmenkari, H., Stougaard, E. B., Mattila, I., Hansen, T. W., Legido-Quigley, C., Hörkkö, S., Forsblom, C., Groop, P-H., Lehto, M. & Rossing, P., 1 jun. 2022, I: Diabetes. Volume 71, Issue Supplement_1

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftpeer review

  12. Udgivet

    Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes

    Al-Sari, N., Kutuzova, S., Suvitaival, T., Henriksen, P., Pociot, F., Rossing, P., McCloskey, D. & Legido-Quigley, C., jun. 2022, I: EBioMedicine. 80, s. 104032 104032.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  13. Udgivet
  14. Udgivet
  15. Udgivet
  16. Udgivet
  17. Udgivet

    Effect of the Glucagon-like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

    Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, P., Wolthers, B., Zinman, B. & Perkovic, V., 22 feb. 2022, I: Circulation. 145, 8, s. 575-585 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  18. Udgivet

    Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses from the FIGARO-DKD Trial

    FIGARO-DKD Investigators, 8 feb. 2022, I: Circulation. 145, 6, s. 437-447 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  19. Udgivet

    The authors reply: KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    Caramori, M. L., Tuttle, K. R., Tandon, N., Tunnicliffe, D. J., de Boer, I. H., Rossing, P. & KDIGO Diabetes Work Group, feb. 2022, I: Kidney International. 101, 2, s. 420-421 2 s.

    Publikation: Bidrag til tidsskriftLetterpeer review

  20. Udgivet
  21. Udgivet

    A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Heerspink, H. J., Cherney, D., Postmus, D., Stefánsson, B. V., Chertow, G. M., Dwyer, J. P., Greene, T., Kosiborod, M., Langkilde, A. M., McMurray, J. J., Correa-Rotter, R., Rossing, P., Sjöström, C. D., Toto, R. D., Wheeler, D. C., DAPA-CKD Trial Committees and Investigators, Hornum, M., Pedersen-Bjergaard, U. & Hansen, D., jan. 2022, I: Kidney International. 101, 1, s. 174-184 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  22. Udgivet
  23. Udgivet

    Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    Rossing, P., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., Bengtsson, O., Lindberg, M., Langkilde, A. M., Sjöstrand, M., Stefansson, B. V., Karlsson, C., Chertow, G. M. & 7 flere, Hou, F. F., Correa-Rotter, R., Toto, R. D., Wheeler, D. C., McMurray, J. J. V., Heerspink, H. J. L. & DAPA-CKD and DAPA-HF Trial Committees and Investigators, jan. 2022, I: The Lancet Diabetes and Endocrinology. 10, 1, s. 24-34 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  24. Udgivet

    Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial

    Rossing, P., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Amod, A., Marre, M., Joseph, A., Lage, A., Scott, C., Bakris, G. L. & On Behalf Of The Fidelio-Dkd Investigators, jan. 2022, I: Diabetes, Obesity and Metabolism. 24, 1, s. 125-134 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  25. Udgivet

    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

    FIDELIO-DKD Investigators, jan. 2022, I: Kidney International Reports. 7, 1, s. 36-45

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  26. Udgivet

    Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

    Agarwal, R., Joseph, A., Anker, S., Filippatos, G., Rossing, P., Ruilope, L., Pitt, B., Kolkhof, P., Scott, C., Lawatscheck, R., Wilson, D. & Bakris, G., jan. 2022, I: Journal of the American Society of Nephrology. 33, 1, s. 225-237 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  27. Accepteret/In press

    Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

    Waijer, S. W., Provenzano, M., Mulder, S., Rossing, P., Persson, F., Perkovic, V. & Heerspink, H. J. L., 2022, (Accepteret/In press) I: Diabetes, Obesity and Metabolism.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  28. Accepteret/In press

    Microalbuminuria constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, P. & Epstein, M., 2022, (Accepteret/In press) I: The American Journal of Medicine.

    Publikation: Bidrag til tidsskriftReviewpeer review

  29. 2021
  30. Udgivet
  31. Udgivet

    Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

    Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., Ruilope, L. M., FIGARO-DKD Investigators, Pedersen-Bjergaard, U. & Madsbad, S., 9 dec. 2021, I: The New England journal of medicine. 385, 24, s. 2252-2263 12 s., 2110956.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  32. Udgivet
  33. Udgivet

    Effects of the chymase inhibitor fulacimstat in diabetic kidney disease-results from the CADA DIA trial

    Rossing, P., Strand, J., Avogaro, A., Becka, M., Kanefendt, F. & Otto, C., 2 dec. 2021, I: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 36, 12, s. 2263-2273 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  34. Udgivet
  35. Udgivet

    Sodium-Glucose Cotransporter 2 Inhibitors for Diabetes Mellitus Control After Kidney Transplantation: Review of the Current Evidence

    Kanbay, M., Demiray, A., Afsar, B., Karakus, K. E., Ortiz, A., Hornum, M., Covic, A., Sarafidis, P. & Rossing, P., dec. 2021, I: Nephrology. 26, 12, s. 1007-1017 11 s.

    Publikation: Bidrag til tidsskriftReviewpeer review

  36. Udgivet
  37. E-pub ahead of print

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

    Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, P., Ruilope, L. M., Boletis, J., Toto, R., Umpierrez, G. E., Wanner, C., Wada, T., Scott, C., Joseph, A., Ogbaa, I., Roberts, L., Scheerer, M. F. & Bakris, G. L., 25 nov. 2021, (E-pub ahead of print) I: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  38. E-pub ahead of print

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: A prespecified analysis of the DAPA-CKD trial

    Wheeler, D. C., Jongs, N., Stefansson, B. V., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J. V., Rossing, P., Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjöström, C. D., Toto, R. D., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, 25 nov. 2021, (E-pub ahead of print) I: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  39. Udgivet

    New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race

    Chronic Kidney Disease Epidemiology Collaboration, 4 nov. 2021, I: The New England journal of medicine. 385, 19, s. 1737-1749 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  40. Udgivet

    Distinct Molecular Signatures of Clinical Clusters in People with Type 2 Diabetes: an IMI-RHAPSODY Study

    Slieker, R. C., Donnelly, L. A., Fitipaldi, H., Bouland, G. A., Giordano, G. N., Åkerlund, M., Gerl, M. J., Ahlqvist, E., Ali, A., Dragan, I., Elders, P., Festa, A., Hansen, M. K., van der Heijden, A. A., Aly, D. M., Kim, M., Kuznetsov, D., Mehl, F., Klose, C., Simons, K. & 15 flere, Pavo, I., Pullen, T. J., Suvitaival, T., Wretlind, A., Rossing, P., Lyssenko, V., Quigley, C. L., Groop, L., Thorens, B., Franks, P. W., Ibberson, M., Rutter, G. A., Beulens, J. W., 't Hart, L. M. & Pearson, E. R., nov. 2021, I: Diabetes. 70, 11, s. 2683-2693 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  41. Udgivet

    Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial

    Heerspink, H., Xie, D., Bakris, G., Correa-Rotter, R., Hou, F-F., Kitzman, D., Kohan, D., Makino, H., McMurray, J., Perkovic, V., Rossing, P., Parving, H-H. & de Zeeuw, D., nov. 2021, I: Journal of the American Society of Nephrology. 32, 11, s. 2900-2911 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  42. Udgivet

    Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    DAPA-CKD Trial Committees and Investigators, nov. 2021, I: The Lancet Diabetes and Endocrinology. 9, 11, s. 743-754 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  43. Udgivet

    Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    DAPA-CKD Trial Committees and Investigators, nov. 2021, I: The Lancet Diabetes and Endocrinology. 9, 11, s. 755-766 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  44. Udgivet

    Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

    McMurray, J. J. V., Wheeler, D. C., Stefánsson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., Chertow, G. M., Hou, F. F., Rossing, P., Sjöström, C. D., Solomon, S. D., Toto, R. D., Langkilde, A. M., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, nov. 2021, I: JACC. Heart failure. 9, 11, s. 807-820 14 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  45. Udgivet
  46. Udgivet
  47. Udgivet
  48. Udgivet

    Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes

    Mychaleckyj, J., Valo, E., Ichimura, T., Ahluwalia, T., Dina, C., Miller, R., Shabalin, I., Gyorgy, B., Cao, J., Onengut-Gumuscu, S., Satake, E., Smiles, A., Haukka, J., Tregouet, D-A., Costacou, T., O'Neil, K., Paterson, A., Forsblom, C., Keenan, H., Pezzolesi, M. & 16 flere, Pragnell, M., Galecki, A., Rich, S., Sandholm, N., Klein, R., Klein, B., Susztak, K., Orchard, T., Korstanje, R., King, G., Hadjadj, S., Rossing, P., Bonventre, J., Groop, P-H., Warram, J. & Krolewski, A., okt. 2021, I: Journal of the American Society of Nephrology : JASN. 32, 10, s. 2634-2651 18 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  49. Udgivet

    The low-expression variant of FABP4 is associated with cardiovascular disease in type 1 diabetes

    FinnDiane study group, okt. 2021, I: Diabetes. 70, 10, s. 2391-2401 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  50. Udgivet

    Metabolomic Risk Predictors of Diabetic Foot Ulcers

    Andersen, J. H., Suvitaival, T., Frimodt-Møller, M., Rossing, P., Mattila, I., Trošt, K., Theilade, S., Legido-Quigley, C., Ahluwalia, T. S. & Rasmussen, A., 24 sep. 2021.

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  51. Udgivet
  52. Udgivet
Forrige 1 2 3 4 5 6 7 8 ...14 Næste

ID: 50137657